BOLT
NASDAQ · Biotechnology
Bolt Biotherapeutics Inc
$6.17
+0.26 (+4.40%)
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+327.4% upside
Low Target
$21.16
Average Target
$26.37
High Target
$30.50
Current Price
$6.17
Current
$6.17
$6.17
Target
$26.37
$26.37
$21.16
$26.37 avg
$30.50
Scenario Analysis
Bear Case
$21.16
242.9%
Low target
Base Case
$26.37
+327.4%
Avg target
Bull Case
$30.50
+394.3%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$7.78
-20.7% from high
52-Week Low
$3.10
+99.0% from low
Target vs 52W High
$26.37
+238.9% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.5% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |